Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

ClinicalTrials.gov ID: NCT01586533

Public ClinicalTrials.gov record NCT01586533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa™ Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This double-blind, randomized, comparator-controlled Phase II study is designed to establish the safety and efficacy of Zoenasa Rectal Gel compared to mesalamine enema in subjects with left-sided ulcerative colitis, as measured by the modified ulcerative colitis disease activity index (UCDAI), over 6 weeks of treatment. In this study, two cohorts of subjects will receive either Zoenasa-1:4 (1.0g NAC; 4.0g 5-ASA) investigational drug enema therapy or comparator mesalamine enema (4.0g 5-ASA). The study will enroll subjects randomized equally into the 2 cohorts. Each cohort will enroll approximately 60 subjects. The two arms of the trial will be enrolled concurrently in a randomized fashion.

Study identification

NCT ID
NCT01586533
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Altheus Therapeutics, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Apr 2014 (Estimated)
Completion
Not listed
Last update posted
Jan 8, 2014

Started 2012

United States locations

U.S. sites
45
U.S. states
21
U.S. cities
42
Facility City State ZIP Site status
Birmingham Gastroenterology Associates Birmingham Alabama 35209 —
Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
Rocky Mountain Gastroenterology Lakewood Colorado 80214 —
Digestive Disease Associates Gainesville Florida 32605 —
Digestive Medical Associates Hialeah Florida 33016 —
The Center for Gastrointestinal Disorders Hollywood Florida 33021 —
Miami Gastroenterology Consultants P.A. Miami Florida 33156 —
South Medical Research Group Miami Florida 33186 —
Gastroenterology of Naples Naples Florida 34102 —
Advanced Gastroenterology Associates Palm Harbor Florida 34684 —
Shafran Gastroenterology Winter Park Florida 32789 —
Tri-County Research Athens Georgia 30606 —
Digestive Healthcare of Georgia Atlanta Georgia 30309 —
The Atlanta Center for Gastroenterology Decatur Georgia 30033 —
St. Josephs Candler Health System Savannah Georgia 31405 —
NCH Medical Group Arlington Heights Illinois 60004 —
Gastrointestinal Clinic of Quad Cities Davenport Iowa 52807 —
Professional Research Network of Kansas Wichita Kansas 67203 —
Clinical Trials Management of Louisiana Metairie Louisiana 70006 —
Dr. Jason Bozdin, M.D. Berkley Michigan 48072 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
Gregory Cammel, MD PLC Wyoming Michigan 48418 —
GI Associates and Endoscopy Center Jackson Mississippi 39202 —
Long Island Clinical Research Associates Great Neck New York 11021 —
Research Associates of New York New York New York 10028 —
Asheville Gastroenterology Associates, P.A. Asheville North Carolina 28801 —
Carolina Digestive Health Associates Davidson North Carolina 28036 —
LeBauer Research Associates, P.A. Greensboro North Carolina 27403 —
Greater Cincinnati Gastroenterology Cincinnati Ohio 45219 —
Central Sooner Research Norman Oklahoma 73071 —
Oklahoma Foundation for Digestive Research Oklahoma City Oklahoma 73104 —
Options Health Research Tulsa Oklahoma 74104 —
Gastroenterology United Tulsa Tulsa Oklahoma 74135 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Gastro One Germantown Tennessee 38138 —
Memphis Gastroenterology Group Germantown Tennessee 38138 —
Dallas VA Medical Center Dallas Texas 75216 —
Houston Digestive Disease Clinic Houston Texas 77090 —
Digestive Health Associates of Texas Plano Texas 75075 —
Advanced Research Institute South Ogden Utah 84405 —
New River Valley Research Institute Christiansburg Virginia 24073 —
Digestive & Liver Disease Specialists Norfolk Virginia 23502 —
Digestive Disease Institute Seattle Washington 98101 —
Franciscan Research Center Tacoma Washington 98405 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01586533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01586533 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →